Published in
Wiley, British Journal of Haematology, 5(195), p. 710-721, 2021
DOI: 10.1111/bjh.17751
Links
Tools
Adoptive immunotherapy with double‐bright (CD56<sup>bright</sup>/CD16<sup>bright</sup>) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof‐of‐concept study
Journal article published in 2021 by
Lucia Silla 
,
Vanessa Valim,
Annelise Pezzi ,
Maria da Silva,
Ianae Wilke,
Juliana Nobrega,
Alini Vargas,
Bruna Amorin,
Bruna Correa,
Bruna Zambonato,
Fernanda Scherer,
Joice Merzoni,
Leo Sekine,
Helen Huls,
Laurence J. Cooper
and other authors.
,
Vanessa Valim,
Annelise Pezzi ,
Maria da Silva,
Ianae Wilke,
Juliana Nobrega,
Alini Vargas,
Bruna Amorin,
Bruna Correa,
Bruna Zambonato,
Fernanda Scherer,
Joice Merzoni,
Leo Sekine,
Helen Huls,
Laurence J. Cooper
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 